z-logo
open-access-imgOpen Access
Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies
Author(s) -
Subhash Thuluva,
Vikram Paradkar,
Kishore Thuraga,
SubbaReddy Gunneri,
Vijay Yerroju,
Rammohanreddy Mogulla,
Mahesh Kyasani,
Senthilkumar Manoharan,
Guruprasad R. Medigeshi,
Janmejay Singh,
Heena Shaman,
Chandramani Singh,
Venkateshwar Rao A
Publication year - 2022
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.4053490
Subject(s) - immunogenicity , virology , selection (genetic algorithm) , computational biology , medicine , biology , immunology , computer science , antibody , artificial intelligence

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom